- Report
- December 2023
- 80 Pages
South Korea
From €1421EUR$1,500USD£1,200GBP
- Report
- December 2023
- 80 Pages
United States
From €1421EUR$1,500USD£1,200GBP
- Report
- December 2023
- 80 Pages
United Kingdom
From €1421EUR$1,500USD£1,200GBP
From €1421EUR$1,500USD£1,200GBP
- Report
- December 2023
- 80 Pages
Poland
From €1421EUR$1,500USD£1,200GBP
- Report
- December 2023
- 80 Pages
China
From €1421EUR$1,500USD£1,200GBP
- Report
- December 2023
- 80 Pages
Argentina
From €1421EUR$1,500USD£1,200GBP
- Report
- February 2024
- 86 Pages
Global
From €3500EUR$3,957USD£3,057GBP
- Report
- January 2025
- 75 Pages
Global
From €3500EUR$3,957USD£3,057GBP
- Report
- February 2024
- 102 Pages
Global
From €3500EUR$3,957USD£3,057GBP
- Report
- October 2023
- 104 Pages
Global
From €3500EUR$3,957USD£3,057GBP
- Report
- December 2022
- 44 Pages
Global
From €1895EUR$2,000USD£1,599GBP
- Report
- September 2022
- 383 Pages
Global
From €2369EUR$2,500USD£1,999GBP
- Report
- December 2023
- 100 Pages
Africa
From €1895EUR$2,000USD£1,599GBP
- Report
- December 2023
- 80 Pages
Brazil
From €1421EUR$1,500USD£1,200GBP
- Report
- December 2023
- 80 Pages
Ireland
From €1421EUR$1,500USD£1,200GBP
- Report
- December 2023
- 80 Pages
Japan
From €1421EUR$1,500USD£1,200GBP
- Report
- December 2023
- 80 Pages
Russia
From €1421EUR$1,500USD£1,200GBP
- Report
- December 2023
- 80 Pages
Vietnam
From €1421EUR$1,500USD£1,200GBP

The antimalarial market is a subset of the infectious diseases drugs market, which focuses on the treatment and prevention of malaria. Antimalarial drugs are used to treat and prevent the spread of the Plasmodium parasite, which is responsible for the disease. These drugs are typically administered orally, intravenously, or intramuscularly, depending on the severity of the infection. Common antimalarial drugs include chloroquine, artemisinin, and mefloquine.
In addition to antimalarial drugs, the market also includes insecticides, insect repellents, and other preventive measures. These products are used to reduce the risk of infection by controlling the mosquito population, which is the primary vector for the Plasmodium parasite.
Notable companies in the antimalarial market include GlaxoSmithKline, Sanofi, Novartis, and Merck. These companies produce a variety of antimalarial drugs, insecticides, and other preventive measures. Show Less Read more